CB1 Receptor

84 Items found

Search Products:

Enter Catalogue #, CAS # , Chemical Name or Mol Formula:

Advance Search

Search by Category


Search by Parent Drug

  • A101200
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • A105960
    AB-CHMINACA
    1185887-21-1
    C₂₀H₂₈N₄O₂
    N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide; (S)-N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
  • A105970
    AB-CHMINACA 2’-Indazole Isomer RM
    C₂₀H₂₈N₄O₂
    (S)-N-(1-Amino-3-methyl-1-oxobutan-2-yl)-2-(cyclohexylmethyl)-2H-indazole-3-carboxamide;
  • A105975
    AB-CHMINACA Metabolite M1A
    C₂₀H₂₈N₄O₃
    N-((S)-1-Amino-3-methyl-1-oxobutan-2-yl)-1-((3-hydroxycyclohexyl)methyl)-1H-indazole-3-carboxamide;
  • A105980
    AB-CHMINACA Metabolite M1B
    C₂₀H₂₈N₄O₃
    (S)-N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-((4-hydroxycyclohexyl)methyl)-1H-indazole-3-carboxamide;
  • A105995
    AB-CHMINACA metabolite M2
    1185887-51-7
    C₂₀H₂₇N₃O₃
    N-[[1-(Cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-L-valine;
  • A106000
    AB-CHMINACA Metabolite M2 Methyl Ester
    1971007-96-1
    C₂₁H₃₁N₃O₃
    AMB N-Methylcyclohexyl Analog; Methyl [(1S)-(Cyclohexylmethyl)-1H-indazole-3-carbonyl]-L-valinate
  • A106005
    AB-CHMINACA metabolite M3A
    C₂₀H₂₇N₃O₄
    (1-((4-Hydroxycyclohexyl)methyl)-1H-indazole-3-carbonyl)-L-valine;
  • A106010
    AB-CHMINACA metabolite M5A
    C₁₅H₁₈N₂O₃
    1-((4-hydroxycyclohexyl)methyl)-1H-indazole- 3-carboxylic Acid
  • A106025
    AB-CHMINACA metabolite M7
    C₂₀H₂₅N₃O₅
    2-(1-(Cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylsuccinic Acid
  • A575850
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • A575852
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • A603135
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • A603155
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • A609740
    4-Amino-3-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-2-methyl-4-oxobutanoic Acid
    C₂₀H₁₉FN₄O₄
    AB-Fubinaca Metabolite 2
  • A729280
    APP-FUBINACA RM
    1185282-03-4
    C₂₄H₂₁F₄N₄O₂
    N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-1-[(4-fluorophenyl)methyl]-1H-indazole- 3-carboxamide;
  • A765035
    Arachidonyl-2’-fluoroethylamide
    166100-37-4
    C₂₂H₃₆FNO
    (all-Z)-N-(2-Fluoroethyl)-5,8,11,14-eicosatetraenamide; (5Z,8Z,11Z,14Z)-N-(2-Fluoroethyl)-5,8,11,14-eicosatetraenamide
  • A765050
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • A765052
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • A765130
    O-Arachidonoyl Ethanolamine Hydrochloride
    443129-35-9
    C₂₂H₃₆NO₂•HCl
  • A794723
    AVE-1625
    358970-97-5
    C₂₃H₂₀Cl₂F₂N₂O₂S
    N-[1-[Bis(4-chlorophenyl)methyl]azetidin-3-yl]-N-(3,5-difluorophenyl)methanesulfonamide; Drinabant; N-[1-[Bis(4-chlorophenyl)methyl]-3-azetidinyl]-N-(3,5-difluorophenyl)methanesulfonamide;
  • B119085
    BB-22 3-Carboxyindole Metabolite
    858515-71-6
    C₁₆H₁₉NO₂
    1-(Cyclohexylmethyl)-1H-indole-3-carboxylic Acid
  • B682040
    t-Butyl 4-Bromobutyrate
    110661-91-1
    C₈H₁₅BrO₂
    4-Bromobutanoic Acid tert-butyl Ester; 4-Bromobutyric Acid tert-Butyl Ester; tert-Butyl 4-Bromobutanoate; tert-Butyl 4-Bromobutyrate;
  • B686178
    N-(4-Bromopheneethyl-phthalimide
    124499-18-9
    C₁₆H₁₂BrNO₂
    2-[2-(4-Bromophenyl)ethyl]-1H-isoindole-1,3(2H)-dione; N-[2-(4-Bromophenyl)ethyl]phthalimide;
  • C175370
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • C175372
    ---
    ---
    ---
    ---
    This is a controlled substance:Pending Status
  • C369775
    (Z)-1-Chloro-2-nonene
    67242-75-5
    C₉H₁₇Cl
    (2Z)-1-Chloro-2-nonene
  • C377830
    5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic Acid
    162758-35-2
    C₁₇H₁₁Cl₃N₂O₂
    1-(2,4-Dichlorophenyl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic Acid; 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic Acid;
  • C377832
    5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic Acid-13C,d7
    C₁₆¹³CH₄D₇Cl₃N₂O₂
    1-(2,4-Dichlorophenyl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic Acid-13C,d7 ; 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic Acid-13C,d7;
  • C377930
    (2Z)-1-Chloro-2-decene
    135457-18-0
    C₁₀H₁₉Cl
  • C834710
    Cumyl-THPINACA RM
    1400742-50-8
    C₂₃H₂₇N₃O₂
    N-(1-Methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide
  • D225473
    cis-2-Decen-1-ol
    4194-71-2
    C₁₀H₂₀O
    2(Z)-2-Decen-1-ol; (Z)-2-Decen-1-ol
  • D436100
    1-(2,4-Dichlorophenyl)-4-methyl-5-(4-nitrophenyl)-1H-pyrazole-3-carboxylic Acid Ethyl Ester
    221385-24-6
    C₁₉H₁₅Cl₂N₃O₄
  • D436110
    1-(2,4-Dichlorophenyl)-4-methyl-5-phenyl-1H-pyrazole-3-carboxylic Acid Ethyl Ester
    221385-23-5
    C₁₉H₁₆Cl₂N₂O₂
  • E477895
    (all-Z)-5,8,11,14-Eicosatetraenylphosphonofluoridic Acid Methyl Ester
    188404-10-6
    C₂₁H₃₆FO₂P
    P-(5Z,8Z,11Z,14Z)-5,8,11,14-eicosatetraen-1-ylphosphonofluoridic Acid Methyl Ester; Methyl Arachidonyl Fluorophosphonate
  • F101100
    rac-Falcarinol
    4117-12-8
    C₁₇H₂₄O
    (9Z)-1,9-Heptadecadiene-4,6-diyn-3-ol; (cis)-3-Hydroxy-1,9-heptadecadien-4,6-diyne; Panaxynol;
  • F595105
    1-(4-Fluorophenyl)-1-methylethylamine
    17797-10-3
    C₉H₁₂FN
    4-Fluoro-α,α-dimethyl-benzenemethanamine; p-Fluoro-α,α-dimethyl-benzylamine; 2-(4-Fluorophenyl)propan-2-amine; α,α-Dimethyl-4-fluorobenzylamine
  • G932015
    GP 2A
    919077-81-9
    C₂₄H₂₃Cl₂N₃O
  • H295720
    (2Z)-2-(1-Hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene) Hydrazide Benzoic Acid
    1048973-47-2
    C₂₁H₂₃N₃O₂
    MDA 19
  • H673500
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • H673502
    ---
    ---
    ---
    ---
    This is a controlled substance:Narcotic Schedule II
  • J211365
    JWH-031 2’-Isomer
    1797106-18-3
    C₂₁H₂₃NO
    (1-Hexyl-1H-pyrrol-2-yl)naphthalen-1-yl)methanone;
  • J211385
    JWH 071
    209414-05-1
    C₂₁H₁₇NO
    (1-Ethyl-1H-indol-3-yl)-1-naphthalenymethanone;
  • J211420
    JWH-175
    619294-35-8
    C₂₄H₂₅N
    3-(1-Naphthalenylmethyl)-1-pentyl-1H-indole; JWH 175;
  • J211422
    JWH-175-d11
    1794828-59-3
    C₂₄H₂₄D₁₁N
    3-(1-Naphthalenylmethyl)-1-(pentyl-d11)-1H-indole; JWH 175-d11
  • J211495
    JWH-030
    162934-73-8
    C₂₀H₂₁NO
    Naphthalen-1-yl(1-pentyl-1H-pyrrol-3-yl)methanone; 1-Naphthalenyl(1-pentyl-1H-pyrrol-3-yl)methanone;
  • J211505
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch I
  • J211507
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • J211600
    ---
    ---
    ---
    ---
    This is a controlled substance:Narcotic Schedule II
  • J211602
    ---
    ---
    ---
    ---
    This is a controlled substance:Narcotic Schedule II
  • J211700
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • J211702
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • KIT0330
    ---
    ---
    ---
    ---
    This is a controlled substance:Test Kit
  • KIT1530
    Cannabigerol (1.0 mg/mL in Methanol)
    25654-31-3
    C₂₁H₃₂O₂
    2-[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]-5-pentyl-1,3-benzenediol; (E)-2-(3,7-Dimethyl-2,6-octadienyl)-5-pentyl-1,3-benzenediol; 2-[(2E)-3,7-Dimethyl-2,6-octadienyl]-5-pentyl-1,3-benzenediol; (E)-2-(3,7-Dimethyl-2,6-octadienyl)-5-pentylresorcinol;
  • KIT1805
    N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide (100 µg/mL in Methanol)
    1185282-01-2
    C₂₀H₂₁FN₄O₂
    AB-FUBINACA
  • M104095
    MAB-CHMINACA Metabolite M3
    C₂₁H₂₉N₃O₄
    ADB-CHMINACA Metabolite M3;
  • M104100
    MAB-CHMINACA Metabolite M7
    C₂₁H₂₇N₃O₅
    ADB-CHMINACA Metabolite M7;
  • M104105
    MAB-CHMINACA Metabolite M10
    C₂₁H₂₇N₃O₃
    ADB-CHMINACA Metabolite M10;
  • M199520
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • M199522
    MDMB-CHMICA-d11
    C₂₃H₂₁D₁₁N₂O₃
    (S)-Methyl 2-(1-(Cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate-d11
  • M199530
    ---
    ---
    ---
    ---
    This is a controlled substance:Next for Status
  • M199532
    ---
    ---
    ---
    ---
    This is a controlled substance:Next for Status
  • M199785
    MDMB-FUBINACA
    C₂₂H₂₄FN₃O₃
    MDMB-Bz-F; Methyl (S)-2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3- dimethylbutanoate;
  • M266340
    [6-Methoxy-2-(4-methoxyphenyl)benzo[b]furan-3-yl](4-cyanophenyl)methanone
    176977-56-3
    C₂₄H₁₇NO₄
    4-[[6-Methoxy-2-(4-methoxyphenyl)-3-benzofuranyl]carbonyl]benzonitrile; LY 320135
  • M295365
    ---
    ---
    ---
    ---
    This is a controlled substance:Next for Status
  • M326890
    2-Methyl-1-pentylindole
    42951-36-0
    C₁₄H₁₉N
    1-n-Amyl-2-methylindole; 2-Methyl-1-pentyl-1H-indole
  • M424250
    MJ 15
    944154-76-1
    C₂₃H₁₇Cl₃N₄O
    5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(3-pyridinylmethyl)-1H-pyrazole-3-carboxamide
  • M479000
    MO-CHMINACA
    C₂₂H₃₀N₂O₄
    1-Methoxy 3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate;
  • M524650
    1-Monoarachidin
    35474-99-8
    C₂₃H₃₈O₄
    1-Monoarachidonoyl-rac-glycerol; (all-Z)-(±)-2,3-Dihydroxypropyl 5,8,11,14-eicosatetraenoate; (all-Z)-5,8,11,14-Eicosatetraenoic Acid, 2,3-Dihydroxypropyl Ester; (5Z,8Z,11Z,14Z)-5,8,11,14-Eicosatetraenoic Acid, 2,3-Dihydroxypropyl Ester
  • N385708
    NESS 0327
    494844-07-4
    C₂₄H₂₃Cl₃N₄O
    8-Chloro-1-(2,4-dichlorophenyl)-1,4,5,6-tetrahydro-N-1-piperidinylbenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide; N-(Piperidin-1-yl)-8-chloro-1-(2’,4’-dichlorophenyl)-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide; NESS 0327;
  • N502240
    4-Nitro-benzeneethanol
    100-27-6
    C₈H₉NO₃
    p-Nitro-phenethyl alcohol; 1-(2-Hydroxyethyl)-4-nitrobenzene; 2-(4-Nitrophenyl)-1-ethanol; 2-(4-Nitrophenyl)ethanol; 2-(4-Nitrophenyl)ethyl alcohol; 2-(p-Nitrophenyl)ethanol; 4-Nitrobenzeneethanol; 4-Nitrophenethanol; 4-Nitrophenethyl alcohol; NSC 55519; p-Nitrophenethyl alcohol; p-Nitrophenylethyl alcohol
  • N649720
    (Z)-2-Nonen-1-ol
    41453-56-9
    C₉H₁₈O
    (Z)-2-Nonenyl alcohol; cis-2-Nonen-1-ol; (2Z)-2-Nonen-1-ol
  • O674975
    Org 27569
    868273-06-7
    C₂₄H₂₈ClN₃O
    5-chloro-3-ethyl-N-[2-(4-piperidin-1-ylphenyl)ethyl]-1H-indole-2-carboxamide
  • P227540
    4-Pentyn-1-ol
    5390-04-5
    C₅H₈O
    (3-Hydroxypropyl)acetylene; 1-Hydroxy-4-pentyne; 1-Pentyn-5-ol; 5-Hydroxy-1-pentyne; NSC 5274; Pent-4-yne-1-ol
  • P319240
    Phenyl Bromoacetate
    620-72-4
    C₈H₇BrO₂
    Phenyl 2-Bromoacetate; Phenyl α-Bromoacetate; Bromoacetic Acid Phenyl Ester
  • S560015
    (S)-SLV 319
    464213-10-3
    C₂₃H₂₀Cl₂N₄O₂S
    (4S)-3-(4-Chlorophenyl)-N-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-N’-methyl-4-phenyl-1H-pyrazole-1-carboximidamide; BMS 646256; Ibipinabant; JD 5001;
  • T293095
    6,7,8,9-Tetrahydro-5H-benzocycloheptene-7-carboxylic Acid
    1400229-72-2
    C₁₂H₁₄O₂
  • T293295
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • T293297
    ∆9-Tetrahydrocannabivarol-d5
    498542-85-1
    C₁₉H₁₉D₅O₄
    (-)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-propyl-6H-dibenzo[b,d]pyran-1-ol-d5; (6aR-trans)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-propyl-6H-dibenzo[b,d]pyran-1-ol-d5; (-)-Δ9-trans-Tetrahydrocannabivarin-d5; Δ1-Tetrahydrocannabidivarol-d5; O 4394-d5; THC-V-d5; Tetrahydrocannabivarin; n-Propyl-Δ9-tetrahydrocannabinol-d5; Δ1-Tetrahydrocannabidivarol-d5; Δ9-Tetrahydrocannabivarin-d5; Δ9-Tetrahydrocannabivarol-d5; Δ9-trans-Tetrahydrocannabivarin-d5
  • T796420
    ---
    ---
    ---
    ---
    This is a controlled substance:Pending Status
  • T876515
    (5Z,8Z,11Z,14Z)-2-[[Tris(1-methylethyl)silyl]oxy]-5,8,11,14-eicosatetraenoic Acid 1-[[[Tris(1-methylethyl)silyl]oxy]methyl]ethyl Ester
    223259-26-5
    C₄₁H₇₈O₄Si₂
  • U815412
    ---
    ---
    ---
    ---
    This is a controlled substance:Narcotic Schedule I
  • U815447
    UR-144 N-(5-Hydroxypentyl)-d5
    C₂₁H₂₄D₅NO₂
    XLR11 N-(5-Hydroxypentyl) Metabolite-d5; [1-(5-Hydroxypentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone-2,4,5,6,7-d5
  • U822000
    URB754
    86672-58-4
    C₁₆H₁₄N₂O₂
    6-Methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazine-4-one;
84 Items found
Translate »